Vera Molkenthin

Title: Vera Molkenthin: Innovator in Antibody Humanization

Introduction

Vera Molkenthin is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of antibody humanization. Her innovative work has implications for therapeutic applications and advancements in medical research.

Latest Patents

Vera Molkenthin holds a patent for a method titled "Method for mass humanization of rabbit antibodies." This invention relates to producing a population of nucleic acids that encode proteins with rabbit-derived CDR3 amino acid sequences embedded in human framework sequences. The patent emphasizes the creation of a diverse population of nucleic acids and proteins, which can be utilized in various applications.

Career Highlights

Throughout her career, Vera has worked with prominent companies in the biotechnology sector. She has been associated with Abcheck S.r.o. and Charles River Laboratories, Inc. These experiences have allowed her to apply her expertise in antibody engineering and contribute to significant projects in the industry.

Collaborations

Vera has collaborated with esteemed professionals in her field, including Jacob E. Gunn Glanville and Remko Albert Griep. These partnerships have fostered innovation and have been instrumental in advancing her research and development efforts.

Conclusion

Vera Molkenthin's contributions to the field of antibody humanization highlight her role as a pioneering inventor. Her work continues to influence the biotechnology landscape, paving the way for future advancements in therapeutic applications.